Dear Sir/Ma''am, Please find enclosed herewith 30th Annual Report along with Notice of Annual General Meeting for the financial year 2024-25.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Omkar Pharmachem Ltd has submitted its 30th Annual Report along with the Notice of its 30th Annual General Meeting to BSE. The AGM is scheduled for Wednesday, September 24, 2025 at 11:30 AM at Hotel Kanak, Ellisbridge, Ahmedabad. Key items on the agenda include adoption of audited FY25 financial statements, re-appointment of Managing Director Bhawani Shankar Goyal (who retires by rotation), and appointment of two new Independent Directors — Mrs. Surjeet Kaur (5-year term from June 28, 2025) and Mr. Anupam Kumar Mishra (5-year term from August 27, 2025). Shareholders will also vote on a material related party transaction for payment of remuneration up to Rs. 25 lakh during FY26 to the Company Secretary and CFO (KMPs), which represents about 46.29% of the company's annual consolidated turnover. Additionally, M/s. Maulik Bhavsar and Associates has been proposed as Secretarial Auditor for five years (FY26 to FY30).
This is a routine annual filing with no major operational surprises; the stock price is unlikely to move materially on this news. Shareholders should note the relatively high RPT-to-turnover ratio (46.29%) for KMP remuneration, though this is standard for a small company. Two new independent directors strengthen board oversight going into FY26.